Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1996 Jan;58(1):191–200.

Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample.

G Jarvik 1, E B Larson 1, K Goddard 1, G D Schellenberg 1, E M Wijsman 1
PMCID: PMC1914964  PMID: 8554056

Abstract

The epsilon 4 allele of the apolipoprotein E locus (APOE) has been found to be an important predictor of Alzheimer disease (AD). However, linkage analysis has not clarified the role of APOE in the transmission of AD. The results of the current study provide evidence that the pattern of transmission of memory disorders differs in nuclear families in which the AD-affected proband did carry an epsilon 4 allele versus those families in which the AD-affected proband did not carry an epsilon allele. Further, risk of AD due to APOE genotype in the probands is modified by family history of memory disorders, suggesting gene-by-gene interactions. Family history remained a significant predictor of AD for affected probands with some, but not all, APOE genotypes in a logistic regression analysis. Though nonadditive in the prediction of AD, APOE genotype and family history acted additively in the prediction of age at AD onset. The results of complex segregation analysis were inconsistent with Mendelian segregation of memory disorders both in families of affected probands who did or did not carry an epsilon 4 allele, yet these two groups had significantly different parameter estimates for their transmission models. These results are consistent with gene-by-gene interactions, but also could result from common elements in the familial environment.

Full text

PDF
191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994 Jun;7(2):180–184. doi: 10.1038/ng0694-180. [DOI] [PubMed] [Google Scholar]
  2. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  3. Demenais F. M., Bonney G. E. Equivalence of the mixed and regressive models for genetic analysis. I. Continuous traits. Genet Epidemiol. 1989;6(5):597–617. doi: 10.1002/gepi.1370060505. [DOI] [PubMed] [Google Scholar]
  4. Elston R. C. Segregation analysis. Adv Hum Genet. 1981;11:63-120, 372-3. doi: 10.1007/978-1-4615-8303-5_2. [DOI] [PubMed] [Google Scholar]
  5. Farrer L. A., Myers R. H., Connor L., Cupples L. A., Growdon J. H. Segregation analysis reveals evidence of a major gene for Alzheimer disease. Am J Hum Genet. 1991 Jun;48(6):1026–1033. [PMC free article] [PubMed] [Google Scholar]
  6. Fratiglioni L., Ahlbom A., Viitanen M., Winblad B. Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol. 1993 Mar;33(3):258–266. doi: 10.1002/ana.410330306. [DOI] [PubMed] [Google Scholar]
  7. Goddard K. A., Jarvik G. P., Graham J., McNeney B., Hsu L., Siegmund K., Grosser S., Olson J., Wijsman E. M. Analysis of quantitative risk factors for a common oligogenic disease. Genet Epidemiol. 1995;12(6):759–764. doi: 10.1002/gepi.1370120638. [DOI] [PubMed] [Google Scholar]
  8. Graves A. B., White E., Koepsell T. D., Reifler B. V., van Belle G., Larson E. B., Raskind M. A case-control study of Alzheimer's disease. Ann Neurol. 1990 Dec;28(6):766–774. doi: 10.1002/ana.410280607. [DOI] [PubMed] [Google Scholar]
  9. Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990 Mar;31(3):545–548. [PubMed] [Google Scholar]
  10. Jarvik G. P., Wijsman E. M. Alzheimer's disease and the family effect. Nat Genet. 1994 Oct;8(2):115–115. doi: 10.1038/ng1094-115a. [DOI] [PubMed] [Google Scholar]
  11. Jarvik G. P., Wijsman E. M., Kukull W. A., Schellenberg G. D., Yu C., Larson E. B. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology. 1995 Jun;45(6):1092–1096. doi: 10.1212/wnl.45.6.1092. [DOI] [PubMed] [Google Scholar]
  12. Kukull W. A., Hinds T. R., Schellenberg G. D., van Belle G., Larson E. B. Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease: a test in population-based cases and controls. Neurology. 1992 Mar;42(3 Pt 1):607–614. doi: 10.1212/wnl.42.3.607. [DOI] [PubMed] [Google Scholar]
  13. Larson E. B., Kukull W. A., Teri L., McCormick W., Pfanschmidt M., van Belle G., Sumi M. University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987-1988. Aging (Milano) 1990 Dec;2(4):404–408. [PubMed] [Google Scholar]
  14. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C. E., Jondro P. D., Schmidt S. D., Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995 Aug 18;269(5226):973–977. doi: 10.1126/science.7638622. [DOI] [PubMed] [Google Scholar]
  15. Levy-Lahad E., Wijsman E. M., Nemens E., Anderson L., Goddard K. A., Weber J. L., Bird T. D., Schellenberg G. D. A familial Alzheimer's disease locus on chromosome 1. Science. 1995 Aug 18;269(5226):970–973. doi: 10.1126/science.7638621. [DOI] [PubMed] [Google Scholar]
  16. Li G., Shen Y. C., Li Y. T., Chen C. H., Zhau Y. W., Silverman J. M. A case-control study of Alzheimer's disease in China. Neurology. 1992 Aug;42(8):1481–1488. doi: 10.1212/wnl.42.8.1481. [DOI] [PubMed] [Google Scholar]
  17. Mendez M. F., Underwood K. L., Zander B. A., Mastri A. R., Sung J. H., Frey W. H., 2nd Risk factors in Alzheimer's disease: a clinicopathologic study. Neurology. 1992 Apr;42(4):770–775. doi: 10.1212/wnl.42.4.770. [DOI] [PubMed] [Google Scholar]
  18. Morton N. E., Yee S., Lew R. Complex segregation analysis. Am J Hum Genet. 1971 Nov;23(6):602–611. [PMC free article] [PubMed] [Google Scholar]
  19. Pairitz G., Davignon J., Mailloux H., Sing C. F. Sources of interindividual variation in the quantitative levels of apolipoprotein B in pedigrees ascertained through a lipid clinic. Am J Hum Genet. 1988 Sep;43(3):311–321. [PMC free article] [PubMed] [Google Scholar]
  20. Payami H., Montee K., Kaye J. Evidence for familial factors that protect against dementia and outweigh the effect of increasing age. Am J Hum Genet. 1994 Apr;54(4):650–657. [PMC free article] [PubMed] [Google Scholar]
  21. Pericak-Vance M. A., Bebout J. L., Gaskell P. C., Jr, Yamaoka L. H., Hung W. Y., Alberts M. J., Walker A. P., Bartlett R. J., Haynes C. A., Welsh K. A. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet. 1991 Jun;48(6):1034–1050. [PMC free article] [PubMed] [Google Scholar]
  22. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993 Sep 18;342(8873):697–699. doi: 10.1016/0140-6736(93)91705-q. [DOI] [PubMed] [Google Scholar]
  23. Rao V. S., van Duijn C. M., Connor-Lacke L., Cupples L. A., Growdon J. H., Farrer L. A. Multiple etiologies for Alzheimer disease are revealed by segregation analysis. Am J Hum Genet. 1994 Nov;55(5):991–1000. [PMC free article] [PubMed] [Google Scholar]
  24. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  25. Schellenberg G. D., Bird T. D., Wijsman E. M., Orr H. T., Anderson L., Nemens E., White J. A., Bonnycastle L., Weber J. L., Alonso M. E. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 1992 Oct 23;258(5082):668–671. doi: 10.1126/science.1411576. [DOI] [PubMed] [Google Scholar]
  26. Schellenberg G. D., Payami H., Wijsman E. M., Orr H. T., Goddard K. A., Anderson L., Nemens E., White J. A., Alonso M. E., Ball M. J. Chromosome 14 and late-onset familial Alzheimer disease (FAD). Am J Hum Genet. 1993 Sep;53(3):619–628. [PMC free article] [PubMed] [Google Scholar]
  27. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995 Jun 29;375(6534):754–760. doi: 10.1038/375754a0. [DOI] [PubMed] [Google Scholar]
  28. Sing C. F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985 Mar;37(2):268–285. [PMC free article] [PubMed] [Google Scholar]
  29. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., Roses A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8098–8102. doi: 10.1073/pnas.90.17.8098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tsai M. S., Tangalos E. G., Petersen R. C., Smith G. E., Schaid D. J., Kokmen E., Ivnik R. J., Thibodeau S. N. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet. 1994 Apr;54(4):643–649. [PMC free article] [PubMed] [Google Scholar]
  31. Yu C. E., Payami H., Olson J. M., Boehnke M., Wijsman E. M., Orr H. T., Kukull W. A., Goddard K. A., Nemens E., White J. A. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet. 1994 Apr;54(4):631–642. [PMC free article] [PubMed] [Google Scholar]
  32. van Duijn C. M., Clayton D., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., Mortimer J. A. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. Int J Epidemiol. 1991;20 (Suppl 2):S13–S20. doi: 10.1093/ije/20.supplement_2.s13. [DOI] [PubMed] [Google Scholar]
  33. van Duijn C. M., Farrer L. A., Cupples L. A., Hofman A. Genetic transmission of Alzheimer's disease among families in a Dutch population based study. J Med Genet. 1993 Aug;30(8):640–646. doi: 10.1136/jmg.30.8.640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. van Duijn C. M., de Knijff P., Cruts M., Wehnert A., Havekes L. M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994 May;7(1):74–78. doi: 10.1038/ng0594-74. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES